APYX Stock | | | USD 1.45 0.07 5.07% |
This module uses fundamental data of Apyx Medical to approximate its Piotroski F score. Apyx Medical F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of Apyx Medical. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about Apyx Medical financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Check out
Apyx Medical Altman Z Score,
Apyx Medical Correlation,
Apyx Medical Valuation, as well as analyze
Apyx Medical Alpha and Beta and
Apyx Medical Hype Analysis.
For more information on how to buy Apyx Stock please use our
How to Invest in Apyx Medical guide.
At this time, Apyx Medical's
Debt Ratio is fairly stable compared to the past year. At this time, Apyx Medical's
Book Value Per Share is fairly stable compared to the past year.
Capex To Depreciation is likely to rise to 1.40 in 2025, whereas
Price To Sales Ratio is likely to drop 1.89 in 2025.
At this time, it appears that Apyx Medical's Piotroski F Score is Poor. Although some professional money managers and academia have recently criticized
Piotroski F-Score model, we still consider it an effective method of
predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
4.0
Piotroski F Score - Poor
| Current Return On Assets | Negative | Focus |
| Change in Return on Assets | Increased | Focus |
| Cash Flow Return on Assets | Negative | Focus |
| Current Quality of Earnings (accrual) | Improving | Focus |
| Asset Turnover Growth | Increase | Focus |
| Current Ratio Change | Decrease | Focus |
| Long Term Debt Over Assets Change | Higher Leverage | Focus |
| Change In Outstending Shares | Decrease | Focus |
| Change in Gross Margin | No Change | Focus |
Apyx Medical Piotroski F Score Drivers
The critical factor to consider when applying the Piotroski F Score to Apyx Medical is to make sure Apyx is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Apyx Medical's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Apyx Medical's financial numbers are properly reported.
Apyx Medical F Score Driver Matrix
One of the toughest challenges investors face today is learning how to quickly synthesize historical
financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between Apyx Medical's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Apyx Medical in a much-optimized way.
Click cells to compare fundamentals
About Apyx Medical Piotroski F Score
F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled
Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.
About Apyx Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Apyx Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Apyx Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at
the intrinsic value of Apyx Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing
financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our
fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Apyx Stock Analysis
When running Apyx Medical's price analysis, check to
measure Apyx Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apyx Medical is operating at the current time. Most of Apyx Medical's value examination focuses on studying past and present price action to
predict the probability of Apyx Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apyx Medical's price. Additionally, you may evaluate how the addition of Apyx Medical to your portfolios can decrease your overall portfolio volatility.